https://www.nature.com/articles/s41577-020-00413-x
Abstract
Dendritic cells (DCs) develop in the bone marrow from haematopoietic progenitors that have numerous shared characteristics between mice and humans. Human counterparts of mouse DC progenitors have been identified by their shared transcriptional signatures and developmental potential. New findings continue to revise models of DC ontogeny but it is well accepted that DCs can be divided into two main functional groups. Classical DCs include type 1 and type 2 subsets, which can detect different pathogens, produce specific cytokines and present antigens to polarize mainly naive CD8+ or CD4+ T cells, respectively. By contrast, the function of plasmacytoid DCs is largely innate and restricted to the detection of viral infections and the production of type I interferon. Here, we discuss genetic models of mouse DC development and function that have aided in correlating ontogeny with function, as well as how these findings can be translated to human DCs and their progenitors.
StemVacs Differences
Re: StemVacs - 0:55 / 34:18 Exosomes Webinar 11: Nerve Regeneration
0:55 / 34:18
Exosomes Webinar 11: Nerve Regeneration
Stem Cell Treatment at Swiss Medica
Stem Cell Treatment at Swiss Medica
Re: StemVacs
NEWS 2/16/21 Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board
Developer of First Tumor Vaccine to Receive Regulatory Approval Recruited to Accelerate Clinical Translation of StemVacs Cellular Immunotherapy
Developer of First Tumor Vaccine to Receive Regulatory Approval Recruited to Accelerate Clinical Translation of StemVacs Cellular Immunotherapy
Dr. Abbiati talks about how tissue and bone healing changes as you age
Dr. Abbiati talks about how tissue and bone healing changes as you age
Stem Cells: Why Some Work and Some Don't for Treating Diseases (PAAAMMI 8th Annual Convention)
Stem Cells: Why Some Work and Some Don't for Treating Diseases (PAAAMMI 8th Annual Convention)